(Q54995809)

English

YUSIV

cell line

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

15 July 2024

cancer cell line

1 reference

Cellosaurus release 49

15 July 2024

described by source

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells

1 reference

Cellosaurus release 49

15 July 2024

Phosphoproteomic screen identifies potential therapeutic targets in melanoma

1 reference

Cellosaurus release 49

15 July 2024

MicroRNA signatures differentiate melanoma subtypes

1 reference

Cellosaurus release 49

15 July 2024

Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies

1 reference

Cellosaurus release 49

15 July 2024

Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas

1 reference

Cellosaurus release 49

15 July 2024

Integrated analysis of tumor samples sheds light on tumor heterogeneity

1 reference

Cellosaurus release 49

15 July 2024

established from medical condition

1 reference

Cellosaurus release 49

15 July 2024

derived from organism type

1 reference

Cellosaurus release 49

15 July 2024

Identifiers

1 reference

Cellosaurus release 49

15 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54995809&oldid=2258597163"